Cited by 321Autoimmune and Inflammatory Disorders ResearchKawasaki Disease and Coronary ComplicationsInflammasome and immune disorders

The DOI matches its Crossref record; 15 of the 15 references it cites were found in a registry or an index.

The diagnostic significance of soluble CD163 and soluble interleukin‐2 receptor α‐chain in macrophage activation syndrome and untreated new‐onset systemic juvenile idiopathic arthritis

Bleesing, Jack, Prada, Anne, Siegel, David M., Villanueva, Joyce, Olson, Judyann, Ilowite, Norman T., Brunner, Hermine I., Griffin, Thomas, Graham, Thomas B., Sherry, David D., Passo, Murray H., Ramanan, Athimalaipet V., Filipovich, Alexandra, Grom, Alexei A.·2007·Arthritis & Rheumatism

DOI 10.1002/art.22416

Open this paper in CoChat — free account

Abstract

Objective: Macrophage activation syndrome is characterized by an overwhelming inflammatory reaction driven by excessive expansion of T cells and hemophagocytic macrophages. Levels of soluble interleukin‐2 receptor α (sIL‐2Rα) and soluble CD163 (sCD163) may reflect the degree of activation and expansion of T cells and macrophages, respectively. This study was undertaken to assess the value of serum sIL‐2Rα and sCD163 in diagnosing acute macrophage activation syndrome complicating systemic juvenile idiopathic arthritis (JIA). Methods: Enzyme‐linked immunosorbent assay was used to assess sIL‐2Rα and sCD163 levels in sera from 7 patients with acute macrophage activation syndrome complicating systemic JIA and 16 patients with untreated new‐onset systemic JIA. The results were correlated with clinical features of established macrophage activation syndrome, including ferritin levels. Results: The median level of sIL‐2Rα in the patients with macrophage activation syndrome was 19,646 pg/ml (interquartile range [IQR] 18,128), compared with 3,787 pg/ml (IQR 3,762) in patients with systemic JIA (P = 0.003). Similarly, the median level of sCD163 in patients with macrophage activation syndrome was 23,000 ng/ml (IQR 14,191), compared with 5,480 ng/ml (IQR 2,635) in patients with systemic JIA (P = 0.017). In 5 of 16 patients with systemic JIA, serum levels of sIL‐2Rα or sCD163 were comparable with those in patients with acute macrophage activation syndrome. These patients had high inflammatory activity associated with a trend toward lower hemoglobin levels (P = 0.11), lower platelet counts, and significantly higher ferritin levels (P = 0.02). Two of these 5 patients developed overt macrophage activation syndrome several months later. Conclusion: Levels of sIL‐2Rα and sCD163 are promising diagnostic markers for macrophage activation syndrome. They may also help identify patients with subclinical macrophage activation syndrome.

Integrity signals

Registry

Crossref · 10.1002/art.22416

Cites

15 of 15 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Perforin Gene Defects in Familial Hemophagocytic Lymphohistiocytosis
Stepp, S. E., Dufourcq-Lagelouse, R., Deist, F. L., Bhawan, S., Dogniaux, S., Mathew, P. A., Henter, J., Bennett, M., Fischer, A., Basile, G. D. S., et al. (1999) · Science · doi:10.1126/science.286.5446.1957 · Cited by 1,236
Revision of the proposed classification criteria for juvenile idiopathic arthritis: Durban 1997
Petty, R. E., Southwood, T. R. E., Baum, J., Bhettay, E., Glass, D. N., Manners, P. J., Maldonado-Cocco, J. A., Suarez-Almazor, M. E., Orozco-Alcalá, J., & Prieur, A. (2001) · CRC Press eBooks · doi:10.3109/9780203214237-62 · Cited by 1,175
An animal model of hemophagocytic lymphohistiocytosis (HLH): CD8+ T cells and interferon gamma are essential for the disorder
Jordan, M. B., Hildeman, D., Kappler, J., & Marrack, P. (2004) · Blood · doi:10.1182/blood-2003-10-3413 · Cited by 712
Preliminary diagnostic guidelines for macrophage activation syndrome complicating systemic juvenile idiopathic arthritis
Ravelli, A., Magni‐Manzoni, S., Pistorio, A., Besana, C., Foti, T., Ruperto, N., Viola, S., & Martini, A. (2005) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2004.12.016 · Cited by 409
Macrophage activation syndrome: characteristic findings on liver biopsy illustrating the key role of activated, IFN-γ-producing lymphocytes and IL-6- and TNF-α-producing macrophages
Billiau, A., Roskams, T., Damme‐Lombaerts, R. V., Matthys, P., & Wouters, C. H. (2004) · Blood · doi:10.1182/blood-2004-08-2997 · Cited by 306
Acute hemorrhagic, hepatic, and neurologic manifestations in juvenile rheumatoid arthritis: Possible relationship to drugs or infection
Hadchouel, M., Prieur, A., & Griscelli, C. (1985) · The Journal of Pediatrics · doi:10.1016/s0022-3476(85)80072-x · Cited by 251
Natural killer cell dysfunction is a distinguishing feature of systemic onset juvenile rheumatoid arthritis and macrophage activation syndrome
Villanueva, J. M., Lee, S., Giannini, E. H., Graham, T. B., Passo, M. H., Filipovich, A. H., & Grom, A. A. (2004) · Arthritis Research & Therapy · doi:10.1186/ar1453 · Cited by 240
Self-citation
Elevated soluble interleukin-2 receptor in childhood hemophagocytic histiocytic syndromes
Komp, D., McNamara, J., & Buckley, P. J. (1989) · Blood · doi:10.1182/blood.v73.8.2128.bloodjournal7382128 · Cited by 227
Natural killer cell dysfunction: A common pathway in systemic‐onset juvenile rheumatoid arthritis, macrophage activation syndrome, and hemophagocytic lymphohistiocytosis?
Grom, A. A. (2004) · Arthritis & Rheumatism · doi:10.1002/art.20198 · Cited by 209
Self-citation
Familial and Acquired Hemophagocytic Lymphohistiocytosis
Janka, G., & Stadt, U. Z. (2005) · Hematology · doi:10.1182/asheducation-2005.1.82 · Cited by 203

Flagged first, then by citations

Show all 15 references

Research works printed but not linked: 1

10.1182/blood.V73.8.2128.2128 · DOI

Sorted by citations

Items 101–200 of 321

Alternative activation in systemic juvenile idiopathic arthritis monocytes
Macaubas, C., Nguyen, K. D., Peck, A., Buckingham, J., Deshpande, C., Wong, E., Alexander, H. C., Chang, S.-Y., Begovich, A. B., Sun, Y., et al. (2011) · Clinical Immunology · doi:10.1016/j.clim.2011.12.008 · Cited by 63
Macrophage activation syndrome in children with systemic juvenile idiopathic arthritis and systemic lupus erythematosus
Aytaç, S., Batu, E. D., Ünal, Ş., Bilginer, Y., Çetin, M., Tuncer, M. A., Gümrük, F., & Özen, S. (2016) · Rheumatology International · doi:10.1007/s00296-016-3545-9 · Cited by 61
Ferritin and C-reactive protein are predictive biomarkers of mortality and macrophage activation syndrome in adult onset Still’s disease. Analysis of the multicentre Gruppo Italiano di Ricerca in Reumatologia Clinica e Sperimentale (GIRRCS) cohort
Benedetto, P. D., Cipriani, P., Iacono, D., Pantano, I., Caso, F., Emmi, G., Grembiale, R. D., Cantatore, F. P., Atzeni, F., Perosa, F., et al. (2020) · PLoS ONE · doi:10.1371/journal.pone.0235326 · Cited by 60
Follistatin-like Protein 1 and the Ferritin/Erythrocyte Sedimentation Rate Ratio Are Potential Biomarkers for Dysregulated Gene Expression and Macrophage Activation Syndrome in Systemic Juvenile Idiopathic Arthritis
Gorelik, M., Fall, N., Altaye, M., Barnes, M., Thompson, S. D., Grom, A. A., & Hirsch, R. (2013) · The Journal of Rheumatology · doi:10.3899/jrheum.121131 · Cited by 60
Self-citation
Systematic review: macrophage activation syndrome in inflammatory bowel disease
Fries, W., Cottone, M., & Cascio, A. (2013) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.12305 · Cited by 58
Macrophage Activation Syndrome
Sen, E. S., Clarke, S. L. N., & Ramanan, A. V. (2015) · The Indian Journal of Pediatrics · doi:10.1007/s12098-015-1877-1 · Cited by 59
Self-citation
The liver is populated by a broad spectrum of markers for macrophages. In alcoholic hepatitis the macrophages are M1 and M2
Lee, J., French, B. A., Morgan, T. R. M., & French, S. W. (2013) · Experimental and Molecular Pathology · doi:10.1016/j.yexmp.2013.09.004 · Cited by 58
Immature cell populations and an erythropoiesis gene-expression signature in systemic juvenile idiopathic arthritis: implications for pathogenesis
Hinze, C. H., Fall, N., Thornton, S., Mo, J. Q., Aronow, B. J., Layh‐Schmitt, G., Griffin, T. A., Thompson, S. D., Colbert, R. A., Glass, D. N., et al. (2010) · Arthritis Research & Therapy · doi:10.1186/ar3061 · Cited by 58
Self-citation
The unique aspects of presentation and diagnosis of hemophagocytic lymphohistiocytosis in adults
Nikiforow, S., & Berliner, N. (2015) · Hematology · doi:10.1182/asheducation-2015.1.183 · Cited by 58
Experience With Hemophagocytic Lymphohistiocytosis/Macrophage Activation Syndrome at a Single Institution
Gupta, A. A., Tyrrell, P. N., Valani, R., Benseler, S. M., Abdelhaleem, M. M., & Weitzman, S. S. (2009) · Journal of Pediatric Hematology/Oncology · doi:10.1097/mph.0b013e3181923cb4 · Cited by 57
M2 macrophages and their role in rheumatic diseases
Bhattacharya, S., & Aggarwal, A. (2018) · Rheumatology International · doi:10.1007/s00296-018-4120-3 · Cited by 56
Advances in biomarkers for paediatric rheumatic diseases
Consolaro, A., Varnier, G., Martini, A., & Ravelli, A. (2015) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2014.208 · Cited by 49
IL-1 Inhibition in Systemic Juvenile Idiopathic Arthritis
Giancane, G., Minoia, F., Davì, S., Bracciolini, G., Consolaro, A., & Ravelli, A. (2016) · Frontiers in Pharmacology · doi:10.3389/fphar.2016.00467 · Cited by 55
A xenograft model of macrophage activation syndrome amenable to anti-CD33 and anti–IL-6R treatment
Wunderlich, M., Stockman, C. A., Devarajan, M., Ravishankar, N., Sexton, C., Kumar, A. R., Mizukawa, B. E., & Mulloy, J. C. (2016) · JCI Insight · doi:10.1172/jci.insight.88181 · Cited by 53
Hemophagocytic lymphohistiocytosis in adults
Bhatt, N. S., Oshrine, B. R., & Talano, J. (2018) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.1080/10428194.2018.1482543 · Cited by 53
Current evidence on the use of anakinra in COVID-19
Khani, E., Shahrabi, M., Rezaei, H., Pourkarim, F., Afsharirad, H., & Solduzian, M. (2022) · International Immunopharmacology · doi:10.1016/j.intimp.2022.109075 · Cited by 51
Characteristic elevation of soluble TNF receptor II : I ratio in macrophage activation syndrome with systemic juvenile idiopathic arthritis
Shimizu, M., Inoue, N., Mizuta, M., Nakagishi, Y., & Yachie, A. (2017) · Clinical & Experimental Immunology · doi:10.1111/cei.13026 · Cited by 47
Macrophage activation syndrome in children with Kawasaki disease: diagnostic and therapeutic approaches
Han, S. B., & Lee, S. Y. (2020) · World Journal of Pediatrics · doi:10.1007/s12519-020-00360-6 · Cited by 47
Identification of the best cutoff points and clinical signs specific for early recognition of macrophage activation syndrome in active systemic juvenile idiopathic arthritis
Kostik, M. M., Dubko, M. F., Masalova, V. V., Snegireva, L. S., Kornishina, T., Чикова, И. А., Likhacheva, T. S., Isupova, E. A., Glebova, N. I., Kuchinskaya, E., et al. (2014) · Seminars in Arthritis and Rheumatism · doi:10.1016/j.semarthrit.2014.09.004 · Cited by 46
Macrophage Activation Syndrome-Associated Markers in Severe Dengue
Ab-Rahman, H. A., Rahim, H., AbuBakar, S., & Wong, P. (2016) · International Journal of Medical Sciences · doi:10.7150/ijms.13680 · Cited by 46
The limited role of interferon‐γ in systemic juvenile idiopathic arthritis cannot be explained by cellular hyporesponsiveness
Sikora, K. A., Fall, N., Thornton, S., & Grom, A. A. (2012) · Arthritis & Rheumatism · doi:10.1002/art.34604 · Cited by 45
Self-citation
Application of the Yamaguchi criteria for classification of “suspected” systemic juvenile idiopathic arthritis (sJIA)
Kumar, S., Kunhiraman, D. S., & Rajam, L. (2012) · Pediatric Rheumatology · doi:10.1186/1546-0096-10-40 · Cited by 45
Pathogenesis and Treatment of Refractory Disease Courses in Systemic Juvenile Idiopathic Arthritis
Erkens, R. G. A., Esteban, Y., Towe, C. T., Schulert, G. S., & Vastert, S. J. (2021) · Rheumatic Disease Clinics of North America · doi:10.1016/j.rdc.2021.06.003 · Cited by 45
Hemophagocytic Lymphohistiocytosis
Skinner, J., Yankey, B., & Shelton, B. K. (2019) · AACN Advanced Critical Care · doi:10.4037/aacnacc2019463 · Cited by 45
Presentation and diagnosis of adult-onset Still’s disease: the implications of current and emerging markers in overcoming the diagnostic challenge
Colafrancesco, S., Priori, R., & Valesini, G. (2015) · Expert Review of Clinical Immunology · doi:10.1586/1744666x.2015.1037287 · Cited by 44
Soluble CD163, a unique biomarker to evaluate the disease activity, exhibits macrophage activation in systemic juvenile idiopathic arthritis
Sakumura, N., Shimizu, M., Mizuta, M., Inoue, N., Nakagishi, Y., & Yachie, A. (2018) · Cytokine · doi:10.1016/j.cyto.2018.05.017 · Cited by 44
Monocyte and bone marrow macrophage transcriptional phenotypes in systemic juvenile idiopathic arthritis reveal TRIM8 as a mediator of IFN-γ hyper-responsiveness and risk for macrophage activation syndrome
Schulert, G. S., Pickering, A., Do, T., Dhakal, S., Fall, N., Schnell, D., Medvedovic, M., Salomonis, N., Thornton, S., & Grom, A. A. (2020) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2020-217470 · Cited by 44
Self-citation
Synovial fluid proteins differentiate between the subtypes of juvenile idiopathic arthritis
Rosenkranz, M. E., Wilson, D. C., Marinov, A. D., Decewicz, A., Grof‐Tisza, P., Kirchner, D. R., Giles, B. M., Reynolds, P. R., Liebman, M., Kolli, V. S. K., et al. (2010) · Arthritis & Rheumatism · doi:10.1002/art.27447 · Cited by 44
Association of Variants in IL2RA With Progression of Joint Destruction in Rheumatoid Arthritis
Knevel, R., de Rooy, D. P. C., Zhernakova, A., Gröndal, G., Krabben, A., Steinsson, K., Wijmenga, C., Cavet, G., Toes, R. E. M., Huizinga, T. W. J., et al. (2013) · Arthritis & Rheumatism · doi:10.1002/art.37938 · Cited by 41
Macrophage Activation Marker Soluble CD163 Associated with Fatal and Severe Ebola Virus Disease in Humans1
McElroy, A. K., Shrivastava-Ranjan, P., Harmon, J. R., Martines, R. B., Silva-Flannery, L. M., Flietstra, T. D., Kraft, C. S., Mehta, A. K., Lyon, G. M., Varkey, J. B., et al. (2019) · Emerging infectious diseases · doi:10.3201/eid2502.181326 · Cited by 41
Macrophage Activation Syndrome
Nigrovic, P. A. (2024) · Arthritis & Rheumatology · doi:10.1002/art.43052 · Cited by 40
Soluble CD 163, a Specific Macrophage Activation Marker, is Decreased by Anti‐ TNF ‐ α Antibody Treatment in Active Inflammatory Bowel Disease
Dige, A. K., Støy, S. H., Thomsen, K. L., Hvas, C. L., Agnholt, J. S., Dahlerup, J. F., Møller, H. J., & Grønbæk, H. (2014) · Scandinavian Journal of Immunology · doi:10.1111/sji.12222 · Cited by 40
Contemporary diagnostic methods for hemophagocytic lymphohistiocytic disorders
Johnson, T. S., Villanueva, J. M., Filipovich, A. H., Marsh, R. A., & Bleesing, J. (2010) · Journal of Immunological Methods · doi:10.1016/j.jim.2010.11.006 · Cited by 39
Self-citation
Sepsis with liver dysfunction and coagulopathy predicts an inflammatory pattern of macrophage activation
Anderko, R. R., Gómez, H., Canna, S., Shakoory, B., Angus, D. C., Yealy, D. M., Huang, D. T., Kellum, J. A., Carcillo, J. A., For the ProCESS Investigators, et al. (2022) · Intensive Care Medicine Experimental · doi:10.1186/s40635-022-00433-y · Cited by 37
Macrophage Activation Syndrome
Ravelli, A., Minoia, F., Davì, S., & Martini, A. (2016) · Technical report · doi:10.1016/b978-0-444-63596-9.00004-9 · Cited by 38
Is Still's Disease an Autoinflammatory Syndrome?
Rossi‐Semerano, L., & Koné‐Paut, I. (2012) · International Journal of Inflammation · doi:10.1155/2012/480373 · Cited by 37
Macrophage activation syndrome in children with systemic onset juvenile idiopathic arthritis: clinical experience from northwest India
Singh, S., Chandrakasan, S., Ahluwalia, J., Suri, D., Rawat, A. K., Ahmed, N., Das, R., Sachdeva, M., & Varma, N. (2011) · Rheumatology International · doi:10.1007/s00296-010-1711-z · Cited by 36
Total metabolic lesion volume of lymph nodes measured by 18F-FDG PET/CT: a new predictor of macrophage activation syndrome in adult-onset Still’s disease
Wan, L., Gao, Y., Gu, J., Chi, H., Wang, Z., Hu, Q., Jia, J., Liu, T., Li, B., Teng, J., et al. (2021) · Arthritis Research & Therapy · doi:10.1186/s13075-021-02482-2 · Cited by 32
Plcγ2/Tmem178 dependent pathway in myeloid cells modulates the pathogenesis of cytokine storm syndrome
Mahajan, S., Decker, C. E., Yang, Z., Novack, D. V., Mellins, E., & Faccio, R. (2019) · Journal of Autoimmunity · doi:10.1016/j.jaut.2019.02.005 · Cited by 33
Usefulness of soluble CD163 as a biomarker for macrophage activation syndrome associated with systemic lupus erythematosus
Nishino, A., Katsumata, Y., Kawasumi, H., Hirahara, S., Kawaguchi, Y., & Yamanaka, H. (2019) · Lupus · doi:10.1177/0961203319860201 · Cited by 32
Complications of systemic juvenile idiopathic arthritis: risk factors and management recommendations
Woerner, A., von Scheven-Gête, A., Cimaz, R., & Hofer, M. (2015) · Expert Review of Clinical Immunology · doi:10.1586/1744666x.2015.1032257 · Cited by 32
The Multi-Omics Architecture of Juvenile Idiopathic Arthritis
Hou, X., Qu, H., Zhang, S., Qi, X., Hakonarson, H. H., Xia, Q., & Li, J. (2020) · Cells · doi:10.3390/cells9102301 · Cited by 31
Laboratory parameters identify familial haemophagocytic lymphohistiocytosis from other forms of paediatric haemophagocytosis
Yasumi, T., Hori, M., Hiejima, E., Shibata, H., Izawa, K., Oda, H., Yoshioka, K., Nakagawa, K., Kawai, T., Nishikomori, R., et al. (2015) · British Journal of Haematology · doi:10.1111/bjh.13461 · Cited by 31
The association of soluble CD163, a novel biomarker of macrophage activation, with type 2 diabetes mellitus and its underlying physiological disorders: A systematic review
Semnani-Azad, Z., Mejia, S. B., Connelly, P., Bazinet, R., Retnakaran, R., Jenkins, D., Harris, S., & Hanley, A. (2021) · Obesity Reviews · doi:10.1111/obr.13257 · Cited by 26
Immunoprofiling of active and inactive systemic juvenile idiopathic arthritis reveals distinct biomarkers: a single-center study
Qu, H., Sundberg, E., Aulin, C., Neog, M. K., Palmblad, K., Horne, A., Granath, F. N., Ek, A., Melén, E., Olsson, M., et al. (2021) · Pediatric Rheumatology · doi:10.1186/s12969-021-00660-9 · Cited by 30
Update on the pathogenesis and treatment of systemic idiopathic arthritis
Sikora, K. A., & Grom, A. A. (2011) · Current Opinion in Pediatrics · doi:10.1097/mop.0b013e32834cba24 · Cited by 29
Self-citation
IL2RA is associated with persistence of rheumatoid arthritis
van Steenbergen, H. W., van Nies, J. A. B., Ruyssen‐Witrand, A., Huizinga, T. W. J., Cantagrel, A., Berenbaum, F., & Mil, A. H. M. V. D. H. (2015) · Arthritis Research & Therapy · doi:10.1186/s13075-015-0739-6 · Cited by 29
Hepatic inflammatory pseudotumor presenting in an 8-year-old boy: A case report and review of literature
AlHussaini, H. F. (2015) · World Journal of Gastroenterology · doi:10.3748/wjg.v21.i28.8730 · Cited by 29
A Multiparameter Flow Cytometry Analysis Panel to Assess CD163 mRNA and Protein in Monocyte and Macrophage Populations in Hyperinflammatory Diseases
Thornton, S., Tan, R., Sproles, A. A., Do, T., Schick, J. S., Grom, A. A., DeLay, M. L., & Schulert, G. S. (2019) · The Journal of Immunology · doi:10.4049/jimmunol.1800765 · Cited by 28
Self-citation
Soluble CD 25 in serum: a potential marker for subclinical macrophage activation syndrome in patients with active systemic onset juvenile idiopathic arthritis
Reddy, V. V., Myles, A., Cheekatla, S. S., Singh, S., & Aggarwal, A. (2014) · International Journal of Rheumatic Diseases · doi:10.1111/1756-185x.12196 · Cited by 27
Macrophage activation syndrome complicating rheumatic diseases in adults: case-based review
Gilboa, M., Bornstein, G., Ben‐Zvi, I., & Grossman, C. (2019) · Rheumatology International · doi:10.1007/s00296-019-04393-7 · Cited by 27
Hemophagocytic lymphohistiocytosis: an update for nephrologists
Filippone, E. J., & Farber, J. L. (2016) · International Urology and Nephrology · doi:10.1007/s11255-016-1294-z · Cited by 27
Serum β2-microglobulin level is a useful indicator of disease activity and hemophagocytic syndrome complication in systemic lupus erythematosus and adult-onset Still’s disease
Wakabayashi, K., Inokuma, S., Matsubara, E., Onishi, K., Asashima, H., Nakachi, S., & Hagiwara, K. (2013) · Clinical Rheumatology · doi:10.1007/s10067-013-2220-8 · Cited by 26
MicroRNA networks associated with active systemic juvenile idiopathic arthritis regulate CD163 expression and anti-inflammatory functions in macrophages through two distinct mechanisms
Do, T., Tan, R., Bennett, M. F., Medvedovic, M., Grom, A. A., Shen, N., Thornton, S., & Schulert, G. S. (2017) · Journal of Leukocyte Biology · doi:10.1002/jlb.2a0317-107r · Cited by 26
Self-citation
Refractory macrophage activation syndrome in a patient with SLE and APLA syndrome – Successful use of PET- CT and Anakinra in its diagnosis and treatment
Tayer-Shifman, O. E., & Ben‐Chetrit, E. (2013) · Modern Rheumatology · doi:10.3109/14397595.2013.844403 · Cited by 26
Neutrophil and monocyte activation markers have prognostic impact in disseminated intravascular coagulation: In vitro effect of thrombin on monocyte CD163 shedding
Chung, S., Kim, J.-E., Park, S., Han, K. S., & Kim, H. K. (2011) · Thrombosis Research · doi:10.1016/j.thromres.2010.12.021 · Cited by 26
Successful treatment of macrophage activation syndrome in a patient with dermatomyositis by combination with immunosuppressive therapy and plasmapheresis
Kaieda, S., Yoshida, N., Yamashita, F., Okamoto, M., Ida, H., Hoshino, T., & Fukuda, T. (2013) · Modern Rheumatology · doi:10.3109/14397595.2013.844402 · Cited by 26
Biomarkers in systemic juvenile idiopathic arthritis
Nirmala, N., Grom, A. A., & Gram, H. (2014) · Current Opinion in Rheumatology · doi:10.1097/bor.0000000000000098 · Cited by 25
Self-citation
A review of the pleiotropic actions of the IFN-inducible CXC chemokine receptor 3 ligands in the synovial microenvironment
Dillemans, L., Somer, L. D., Neerinckx, B., & Proost, P. (2023) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-023-04715-w · Cited by 23
Serum Ferritin: A Backstage Weapon in Diagnosis of Dengue Fever
Chaudhuri, S. R., Bhattacharya, S., Chakraborty, M., & Bhattacharjee, K. (2017) · Interdisciplinary Perspectives on Infectious Diseases · doi:10.1155/2017/7463489 · Cited by 24
Circulating Levels of the Shed Scavenger Receptor sCD163 and Association with Outcome of Critically Ill Patients
Ingels, C., Møller, H. J., Hansen, T. K., Wouters, P. J., Vanhorebeek, I., & den Berghe, G. V. (2012) · Journal of Clinical Immunology · doi:10.1007/s10875-012-9830-9 · Cited by 23
Macrophage Activation Syndrome in Children: Update on Diagnosis and Treatment
Lee, J. Y., Bae, K. S., Rhim, J. W., Lee, S. Y., Jeong, D. C., & Kang, J. H. (2024) · Children · doi:10.3390/children11070755 · Cited by 23
Evaluation of macrophage activation syndrome associated with systemic juvenile idiopathic arthritis: single center experience over a one-year period
Barut, K., Yucel, G., Sinoplu, A. B., Şahin, S., Adroviç, A., & Kasapçopur, Ö. (2015) · Türk Pediatri Arşivi · doi:10.5152/turkpediatriars.2015.3299 · Cited by 23
The role of damage-associated molecular pattern for pathogenesis and biomarkers in adult-onset Still’s disease
Jung, J., Suh, C., & Kim, H. (2019) · Expert Review of Molecular Diagnostics · doi:10.1080/14737159.2019.1615449 · Cited by 23
Macrophage Activation Syndrome
Eloseily, E. M., & Cron, R. Q. (2018) · Springer eBooks · doi:10.1007/978-3-319-79026-8_14 · Cited by 26
Clinical features of macrophage activation syndrome in the adult northern Chinese population
Li, X., Qu, B., Nie, Y., Zhu, G., Li, W., & Mu, F. (2014) · Lupus · doi:10.1177/0961203314529467 · Cited by 23
Immune Pathogenesis of COVID-19 Intoxication: Storm or Silence?
Kiselevskiy, M., Shubina, I. Z., Chikileva, I. O., Ситдикова, С. М., Самойленко, И. В., Anisimova, N. Y., Киргизов, К. И., Сулейманова, А. М., Gorbunova, T., & Варфоломеева, С. Р. (2020) · Pharmaceuticals · doi:10.3390/ph13080166 · Cited by 22
Algorithm development for corticosteroid management in systemic juvenile idiopathic arthritis trial using consensus methodology
Ilowite, N. T., Sandborg, C. I., Feldman, B. M., Grom, A., Schanberg, L. E., Giannini, E. H., Wallace, C. A., Schneider, R., Kenney, K., Gottlieb, B. S., et al. (2012) · Pediatric Rheumatology · doi:10.1186/1546-0096-10-31 · Cited by 22
Self-citation
Serum soluble VSIG4 as a surrogate marker for the diagnosis of lymphoma‐associated hemophagocytic lymphohistiocytosis
Yuan, S., Wang, Y., Luo, H., Jiang, Z., Qiao, B., Jiang, Y., Hu, Y., Cheng, Y., Chen, X., Gong, W., et al. (2020) · British Journal of Haematology · doi:10.1111/bjh.16299 · Cited by 21
Monocytes are resistant to apoptosis in systemic juvenile idiopathic arthritis
Srivastava, S., Macaubas, C., Deshpande, C., Alexander, H. C., Chang, S.-Y., Sun, Y., Park, J. L., Lee, T. C., Begovich, A. B., & Mellins, E. (2010) · Clinical Immunology · doi:10.1016/j.clim.2010.04.003 · Cited by 21
Macrophage Activation Syndrome Associated with Adult-Onset Still’s Disease Successfully Treated with Anakinra
Kumar, A., & Kato, H. (2016) · Case Reports in Rheumatology · doi:10.1155/2016/3717392 · Cited by 20
Urinary CD163 is a marker of active kidney disease in childhood-onset lupus nephritis
Inthavong, H., Vanarsa, K., Castillo, J., Hicks, J. M., Mohan, C., & Wenderfer, S. E. (2022) · Lara D. Veeken · doi:10.1093/rheumatology/keac465 · Cited by 18
Toward the Development of New Diagnostic Criteria for Macrophage Activation Syndrome in Systemic Juvenile Idiopathic Arthritis
Dav, S., Lattanzi, B., Demirkaya, E., Rosina, S., Bracciolini, G., Novelli, A., Ruperto, N., Martini, A., Cron, R. Q., & Ravelli, A. (2012) · Annals of Paediatric Rheumatology · doi:10.5455/apr.020620120233 · Cited by 18
Prevalence and Outcome of Secondary Hemophagocytic Lymphohistiocytosis Among SIRS Patients: Results from a Prospective Cohort Study
Gualdoni, G. A., Hofmann, G., Wohlfarth, P., Winkler, H., Winkler, S., Haslacher, H., Thalhammer, R., Makristathis, A., Ratzinger, F., & Burgmann, H. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm8040541 · Cited by 18
A 21‐year‐old man with Still's disease with fever, rash, and pancytopenia
Mehta, B. M., Hashkes, P. J., Avery, R. K., & Deal, C. L. (2010) · Arthritis Care & Research · doi:10.1002/acr.20001 · Cited by 17
IDO1 Deficiency Does Not Affect Disease in Mouse Models of Systemic Juvenile Idiopathic Arthritis and Secondary Hemophagocytic Lymphohistiocytosis
Put, K., Brisse, E., Avau, A., Imbrechts, M., Mitera, T., Janssens, R., Proost, P., Fallarino, F., Wouters, C. H., & Matthys, P. (2016) · PLoS ONE · doi:10.1371/journal.pone.0150075 · Cited by 17
Biomarkers in Systemic Juvenile Idiopathic Arthritis, Macrophage Activation Syndrome and Their Importance in COVID Era
Ailioaie, L. M., Ailioaie, C., & Litscher, G. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232112757 · Cited by 16
Microglial/macrophage markers CHI3L1, sCD14, and sCD163 in CSF and serum of pediatric inflammatory and non-inflammatory neurological disorders: A case-control study and reference ranges
Pranzatelli, M. R., Tate, E. D., & McGee, N. R. (2017) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2017.09.006 · Cited by 17
Do COVID-19 Infections Result in a Different Form of Secondary Hemophagocytic Lymphohistiocytosis
Chu, R., van Eeden, C., Suresh, S., Sligl, W., Osman, M. S., & Tervaert, J. W. C. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22062967 · Cited by 15
Clinical features of pediatric autoimmune hepatitis in Japan: A nationwide survey
Sogo, T., Takahashi, A., Inui, A., Fujisawa, T., Ohira, H., Takikawa, H., & Japan AIH Study Group (JAIHSG) (2017) · Hepatology Research · doi:10.1111/hepr.12998 · Cited by 15
Monitoring serum IL-18 levels is useful for treatment of a patient with systemic juvenile idiopathic arthritis complicated by macrophage activation syndrome
Shigemura, T., Yamazaki, T., Hara, Y., Ou, J.-N., Stevens, A. M., Ochs, H. D., Koike, K., & Agematsu, K. (2011) · Pediatric Rheumatology · doi:10.1186/1546-0096-9-15 · Cited by 15
Dengue death with evidence of hemophagocytic syndrome and dengue virus infection in the bone marrow
Ab-Rahman, H. A., Wong, P., Rahim, H., Abd‐Jamil, J., Tan, K., Sulaiman, S., Lum, C.-S., Omar, S. F. S., & AbuBakar, S. (2015) · SpringerPlus · doi:10.1186/s40064-015-1463-z · Cited by 15
Serum cytokine panels in pediatric clinical practice
Gallo, P. M., Kim, J., McNerney, K. O., Diorio, C. J., Foley, C., Kagami, L. A. T., Wagner, K. M., Petrosa, W. L., Conlon, H., Gollomp, K. L., et al. (2024) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2024.08.030 · Cited by 17
Serum soluble CD163 levels in patients with influenza-associated encephalopathy
Hasegawa, S., Matsushige, T., Inoue, H., Wakabayashi‐Takahara, M., Kajimoto, M., Momonaka, H., Ishida, C., Tanaka, S., Morishima, T., & Ichiyama, T. (2012) · Brain and Development · doi:10.1016/j.braindev.2012.10.005 · Cited by 14
Adult-Onset Still’s Disease
Mitrovic, S., Feist, E., & Fautrel, B. (2019) · Rare diseases of the immune system · doi:10.1007/978-3-030-19055-2_6 · Cited by 14
Mouse models of systemic juvenile idiopathic arthritis and macrophage activation syndrome
Inoue, N., & Schulert, G. S. (2023) · Arthritis Research & Therapy · doi:10.1186/s13075-023-03032-8 · Cited by 14
Molecular Pathways in the Pathogenesis of Systemic Juvenile Idiopathic Arthritis
Schulert, G. S., & Kessel, C. (2023) · Rheumatic Disease Clinics of North America · doi:10.1016/j.rdc.2023.06.007 · Cited by 16
Sudden Hypotension and Increased Serum Interferon-γ and Interleukin-10 Predict Early Macrophage Activation Syndrome in Patients with Systemic Juvenile Idiopathic Arthritis
Guo, L., Xu, Y., Qian, X., Zou, L., Zheng, R., Teng, L., Zheng, Q., Jung, L. K. L., & Lu, M. (2021) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2021.02.008 · Cited by 14
Human Bocavirus Infection in Children with Gastroenteritis, Brazil
Albuquerque, M. C. M. (2007) · Emerging infectious diseases · doi:10.3201/eid1311060671 · Cited by 14
Tocilizumab in Systemic Juvenile Idiopathic Arthritis: Response Differs by Disease Duration at Medication Initiation and by Phenotype of Disease
Yan, X., Tang, W., Zhang, Z., Zhang, Y., Luo, C., & Tang, X. (2021) · Frontiers in Pediatrics · doi:10.3389/fped.2021.735846 · Cited by 13
Síndrome de activación macrofágica y artritis idiopática juvenil. Resultados de un estudio multicéntrico
Molina, J. G., Muñoz, R. M., & Arocena, J. D. I. (2008) · Anales de Pediatría · doi:10.1157/13116224 · Cited by 13
Macrophage activation syndrome
Lattanzi, B., Davì, S., Rosina, S., Solari, N., Lanni, S., Bracciolini, G., Martini, A., & Ravelli, A. (2012) · Indian Journal of Rheumatology · doi:10.1016/s0973-3698(12)60026-0 · Cited by 13
Soluble cytokine receptor levels in aqueous humour of patients with specific autoimmune uveitic entities: sCD30 is a biomarker of granulomatous uveitis
El‐Asrar, A. M. A., Berghmans, N., Al‐Obeidan, S. A., Gikandi, P. W., Opdenakker, G., Damme, J. V., & Struyf, S. (2019) · Eye · doi:10.1038/s41433-019-0693-7 · Cited by 12
The role of extracellular histones in systemic-onset juvenile idiopathic arthritis
Hu, X. M., Xie, Q., Mo, X., & Jin, Y. (2019) · The Italian Journal of Pediatrics/Italian journal of pediatrics · doi:10.1186/s13052-019-0605-2 · Cited by 12
Kawasaki Disease-Associated Cytokine Storm Syndrome
Ulloa‐Gutiérrez, R., Alphonse, M. P., Dhanranjani, A., & Yeung, R. S. M. (2019) · Springer eBooks · doi:10.1007/978-3-030-22094-5_23 · Cited by 11
Juvenile Idiopathic Arthritis
Ravelli, A., Schiappapietra, B., Verazza, S., & Martini, A. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-803267-1.00007-7 · Cited by 11
Neutrophil activation biomarker pentraxin 3 for diagnosis and monitoring of macrophage activation syndrome occurrence in adult-onset Still's disease
Zhu, D., Chen, L., Meng, J., Wang, M., Ma, Y., Chen, X., Xiao, Y., Yi, D., Shi, H., Sun, Y., et al. (2024) · Journal of Autoimmunity · doi:10.1016/j.jaut.2024.103182 · Cited by 10
Hemophagocytic Lymphohistiocytosis
Chellapandian, D. (2020) · Immunology and Allergy Clinics of North America · doi:10.1016/j.iac.2020.04.003 · Cited by 10
[Hemophagocytic syndrome. Current concepts].
Espinosa-Bautista, K. A., Garciadiego-Fossas, P., & Rodríguez, E. L. (2013) · PubMed · Cited by 10
Plasma Siglec-5 and CD163 as Novel Biomarkers for Fulminant Myocarditis
Zhuang, Y., Wang, J., Li, H., Chen, Y., Chen, C., & Wang, D. W. (2022) · Biomedicines · doi:10.3390/biomedicines10112941 · Cited by 10

Authors: Bleesing, J., Prada, A., Siegel, D. M., Villanueva, J., Olson, J., Ilowite, N. T., Brunner, H. I., Griffin, T., Graham, T. B., Sherry, D. D., Passo, M. H., Ramanan, A. V., Filipovich, A., & Grom, A. A.
Affiliations: Cincinnati Children's Hospital Medical Center (US)
University of Rochester (US)
Medical College of Wisconsin (US)
Albert Einstein College of Medicine (US)
Children's Hospital of Philadelphia (US)
Royal National Hospital for Rheumatic Diseases (GB)
ORCID: Bleesing, Jack
Ilowite, Norman T.
Brunner, Hermine I.
Graham, Thomas B.
Sherry, David D.
Ramanan, Athimalaipet V.
Grom, Alexei A.
Venue: Arthritis & Rheumatism
Publisher: Wiley
Published: 2007-02-27
Volume: 56
Issue: 3
Pages: 965-971
ISSN: 0004-3591 (ISSN-L)
1529-0131
DOI: 10.1002/art.22416
OpenAlex: W2052504835
Cited by: 321
References: 15
Citations by year: 2026: 7 · 2025: 7 · 2024: 15 · 2023: 9 · 2022: 9 · 2021: 16 · 2020: 14 · 2019: 27 · 2018: 16 · 2017: 22 · 2016: 28 · 2015: 23 · 2014: 22 · 2013: 24 · 2012: 20
FWCI: 8.09
Type: journal article
Language: en
Open access: closed
Licence: onlinelibrary.wiley.com/termsAndConditions#vor (vor)
Locations: Arthritis & Rheumatism (publishedVersion)
PubMed (publishedVersion)
Bristol Research (University of Bristol) (publishedVersion)
Funders: National Institute of Arthritis and Musculoskeletal and Skin Diseases (P01AR048929)
Topics: Health Sciences › Medicine › Hematology › Autoimmune and Inflammatory Disorders Research
Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Kawasaki Disease and Coronary Complications
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Inflammasome and immune disorders
Keywords: macrophage activation syndrome, systemic juvenile idiopathic arthritis, soluble CD163, soluble interleukin-2 receptor alpha, diagnostic biomarkers, ferritin, T cell activation, hemoglobin, platelet count, hemophagocytosis, disease severity prediction, treatment response monitoring
MeSH terms: CD163 Antigen, Adolescent, Arthritis, Juvenile, Child, Child, Preschool, Female, Ferritins, Humans, Macrophage Activation, Macrophages, Male, Prospective Studies, Receptors, Cell Surface, Syndrome, T-Lymphocytes, Antigens, Differentiation, Myelomonocytic, Antigens, CD, Cell Proliferation, Interleukin-2 Receptor alpha Subunit

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

The diagnostic significance of soluble CD163 and soluble interleukin‐2 receptor α‐chain in macrophage activation syndrome and untreated new‐onset systemic juvenile idiopathic arthritis

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks